|Datum:||11. April 2018|
|Zeit:||17.00 Uhr bis 18.00 Uhr|
Demonstrating Value Through Patient Centricity
As an area of unmet medical need becomes more targeted/specialized and hurdles increase in regards to drug approval, pricing and reimbursement, pharmaceutical companies must demonstrate value not only to regulatory authorities through clinical data, but to patients, payers and healthcare professionals.
Lecture Series Spring 2018: The Patient's Voice in Drug Development
In this lecture series, professionals from industries, adademia and patient organizations will share their visions how the patient perspective can become an integral part of the drug development process, and how this relates to public interests, regulatory requirements, the law and international initiatives.